Skymap Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 359.47 Cr
- Satisfied Charges ₹ 292.84 Cr
- Revenue Growth 14.54%
- Profit Growth -95.39%
- Ebitda -18.64%
- Net Worth -34.19%
- Total Assets -16.72%
About Skymap Pharmaceuticals
Skymap Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 June 2006 and has a history of 18 years and eight months. Its registered office is in Delhi, India.
The Corporate was formerly known as Skymap Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹359.47 Cr. The company has closed loans amounting to ₹292.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Garg, Vinod Gupta, and Sanjay Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233DL2006PTC150088
- Company No.
150088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Skymap Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Garg  | Director | 29-Sep-2015 | Current |
| Vinod Gupta | Director | 12-Oct-2017 | Current |
| Sanjay Gupta | Director | 24-Jun-2006 | Current |
Financial Performance of Skymap Pharmaceuticals.
Skymap Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.54% increase. The company also saw a substantial fall in profitability, with a 95.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skymap Pharmaceuticals?
In 2022, Skymap Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glensmith Labs Private LimitedManish Garg and Sanjay Gupta are mutual person
- Skymap Welfare Foundation
Manish Garg and Sanjay Gupta are mutual person
- Skymap Packaging Private Limited
Sanjay Gupta is a mutual person
- Skymap Lifesciences Private Limited
Sanjay Gupta is a mutual person
Cosmax Pharma LlpManish Garg and Sanjay Gupta are mutual person
- Manek Tradex Private Limited
Manish Garg and Sanjay Gupta are mutual person
Charges (Loans)
Open Charges
₹359.47 Cr
Satisfied Charges
₹292.84 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 359.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2020 | Hdfc Bank Limited | ₹9.50 M | Open |
| 02 Aug 2018 | Hdfc Bank Limited | ₹277.09 Cr | Open |
| 02 Jul 2015 | Hdfc Bank Limited | ₹81.44 Cr | Open |
| 23 Jul 2019 | Citi Bank N.A. | ₹8.00 Cr | Satisfied |
| 26 May 2017 | Hdfc Bank Limited | ₹284.84 Cr | Satisfied |
How Many Employees Work at Skymap Pharmaceuticals?
Skymap Pharmaceuticals has a workforce of 314 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skymap Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymap Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Skymap Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Skymap Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Charges
A charge with Hdfc Bank Limited of Rs. 277.09 Cr registered on 02 Aug 2018 with Charge ID 100206277 was modified on 06 Aug 2024.
- Charges
A charge with Hdfc Bank Limited of Rs. 81.44 Cr registered on 02 Jul 2015 with Charge ID 10587853 was modified on 29 Apr 2024.
- Balance Sheet
Skymap Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge registered on 26 May 2017 via Charge ID 100114747 with Hdfc Bank Limited was fully satisfied on 07 Mar 2024.
- Charges
A charge with Hdfc Bank Limited of Rs. 284.84 Cr registered on 26 May 2017 with Charge ID 100114747 was modified on 17 Apr 2023.
Frequently asked questions
What is the Incorporation or founding date of Skymap Pharmaceuticals Private Limited?
Skymap Pharmaceuticals Private Limited was incorporated on 24 Jun 2006.
What is authorized share capital and paid-up capital of Skymap Pharmaceuticals Private Limited?
The authorized share capital of Skymap Pharmaceuticals Private Limited is ₹ 6.50 Cr and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Skymap Pharmaceuticals Private Limited?
Currently 3 directors are associated with Skymap Pharmaceuticals Private Limited.
- Manish Garg
- Vinod Kumar Gupta
- Sanjay Gupta
What is the registered address of Skymap Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Skymap Pharmaceuticals Private Limited is 302 Narmada Block-5 Pocket D-6, Vasant Kunj India, New Delhi, 110070.
What is the corporate identification number (CIN) and company number of Skymap Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Skymap Pharmaceuticals Private Limited is U24233DL2006PTC150088 and the company number is 150088 as per Ministry of Corporate Affairs (MCA).
What is the official website of Skymap Pharmaceuticals Private Limited?
The Official website of Skymap Pharmaceuticals Private Limited is https://www.skymap.in
What has been the recent revenue trend for Skymap Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Skymap Pharmaceuticals Private Limited has risen by 14.54%.
How many employees does Skymap Pharmaceuticals Private Limited currently have?
As Per 2023 financial reports, 314 employees are currently employed by Skymap Pharmaceuticals Private Limited.
What change has been observed in the net worth of Skymap Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Skymap Pharmaceuticals Private Limited has experienced an downturn of -34.19%.
What are the total open charges for Skymap Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Skymap Pharmaceuticals Private Limited amount to ₹ 359.47 Cr.
When was the last Balance Sheet of Skymap Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Skymap Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
KG
Kishori GuptaDirector